RecruitingNCT05232643

A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation

A Multicenter Prospective Observational Double Cohort Study to Evaluate the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Patients Suffering From NVAF.


Sponsor

Bristol-Myers Squibb

Enrollment

720 participants

Start Date

Jul 9, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to provide real-world data useful to address the factors associated to the administration of oral anticoagulants in the elderly population affected by non-valvular atrial fibrillation (NVAF), in Italy, and it's persistence rate after one year.


Eligibility

Min Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This observational study is examining the patterns of blood thinner (anticoagulant) use in elderly Italian patients with non-valvular atrial fibrillation (AFib not caused by a heart valve problem) to understand which clinical factors influence prescribing decisions and patient outcomes. **You may be eligible if...** - You have been diagnosed with non-valvular atrial fibrillation (any type: persistent, permanent, or paroxysmal) confirmed by an ECG - You have not previously taken anticoagulant blood thinners for AFib - You are participating at an Italian study site **You may NOT be eligible if...** - You have already been on anticoagulant therapy for AFib - You have AFib caused by a heart valve condition - You are unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Local Institution - 0001

Milan, MI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05232643


Related Trials